More Articles

Access and Evidence

Could Digital Medicines Improve Access For All?

Danielle Barron, (Sep 4, 2018)

Digital medicines could provide a new roadmap to reimbursement and regulatory approval.

Beyond The Spiel

Danielle Barron, (Aug 31, 2018)

Pharma companies are now offering more than just the medicine, which means marketers have to go that extra mile too.

Want To Emulate A Startup? Here’s How.

Paul Simms, (Aug 28, 2018)

eyeforpharma Chairman, Paul Simms, explains why pharma companies are failing to innovate as they chase short-term revenues.

Wearables: This Season’s Must-Have Marketing Accessory

Andy stone, (Aug 21, 2018)

Medical devices are generating real-world data on patient populations. Are marketers making the most of this opportunity?
Access and Evidence

Talking The Same Language

Adam Chapman, (Aug 10, 2018)

A universal standard for real-world evidence no longer seems quixotic. But how are companies going to do it?
Patients and Medical

Why Patient Organizations Are No Summer Fling For Pharma

Adam Chapman, (Aug 8, 2018)

Pharma companies are forming long-term relationships with patient organizations, a move that is already bearing fruits for both parties.
Access and Evidence

Going Through the Motions

Adam Chapman, (Aug 6, 2018)

Both pharma and payers say they need to talk more, but are they really listening?
Access and Evidence

Navigating the Chaos

Adam Chapman, (Aug 6, 2018)

With the access landscape shifting rapidly, pharma needs to watch its step
Patients and Medical

Flying The Flag For Patients

Hugh Gosling, (Aug 2, 2018)

The Chief Patient Officer is pharma’s face of patient-centricity but how is this relatively new role shaping up?
Access and Evidence

Seeking the Holy Grail of RWE

Adam Chapman, (Aug 2, 2018)

Universal standards for real-world evidence are closer than you might think